MENU
+Compare
RANI
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$1.93
Change
-$0.19 (-8.96%)
Capitalization
188.25M

RANI Rani Therapeutics Holdings Forecast, Technical & Fundamental Analysis

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections... Show more

RANI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RANI with price predictions
Nov 12, 2025

RANI in upward trend: 10-day moving average broke above 50-day moving average on October 17, 2025

The 10-day moving average for RANI crossed bullishly above the 50-day moving average on October 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 05, 2025. You may want to consider a long position or call options on RANI as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

RANI moved above its 50-day moving average on October 17, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RANI advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RANI moved out of overbought territory on October 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 38 cases where RANI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RANI turned negative on November 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RANI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RANI broke above its upper Bollinger Band on October 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RANI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.381) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (59.880) is also within normal values, averaging (322.723).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RANI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RANI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RANI is expected to report earnings to fall 64.58% to -4 cents per share on March 25

Rani Therapeutics Holdings RANI Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.11
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.01
The last earnings report on November 06 showed earnings per share of -11 cents, beating the estimate of -17 cents. With 5.28M shares outstanding, the current market capitalization sits at 188.25M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2051 Ringwood Avenue
Phone
+1 408 457-3700
Employees
140
Web
https://www.ranitherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DELKY28.90N/A
N/A
Delek Group Ltd.
AUHYF1.42N/A
N/A
Anadolu Hayat Sigort As
WLSS2.40N/A
N/A
WELSIS CORP.
SKFOF196.05-0.96
-0.49%
Sika Finanz Ag
TMRC0.94-0.02
-2.32%
Texas Mineral Resources Corp.

RANI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with KZR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+9.28%
KZR - RANI
54%
Loosely correlated
-0.32%
ARTV - RANI
42%
Loosely correlated
+10.86%
IRON - RANI
38%
Loosely correlated
-0.06%
ACHV - RANI
33%
Poorly correlated
-1.05%
ADVM - RANI
32%
Poorly correlated
-0.69%
More